Swedish Orphan Biovitrum
Quick facts
Marketed products
- Alprolix · Other
- ELOCTA
- Kepivance (Palifermin) · Oncology
Palifermin is a recombinant human fibroblast growth factor 7 (FGF-7) that stimulates epithelial cell proliferation and differentiation to promote healing of damaged mucous membranes.
Phase 3 pipeline
- Palifermin before and after · Oncology
Palifermin is a keratinocyte growth factor (KGF) receptor agonist that stimulates epithelial cell proliferation and differentiation to protect and repair oral mucosa. - Palifermin before only · Oncology
Palifermin is a recombinant human fibroblast growth factor 7 (FGF-7) that stimulates epithelial cell proliferation and differentiation to promote healing of damaged mucous membranes. - Physician's Choice medications · Multiple Therapeutic Areas
Physician's Choice medications are a class of treatments that provide a choice between different medications for a specific condition. - Placebo matching Pegcetacoplan · Immunology / Rare Disease
This is a placebo control arm matching the active drug pegcetacoplan, which is a complement C3 inhibitor that blocks the alternative complement pathway. - SEL-212 high-dose · Rheumatology / Gout
SEL-212 is a combination therapy that pairs a uricase enzyme with an immunosuppressant to lower uric acid levels while preventing immune reactions against the enzyme. - SEL-212 low-dose · Oncology
SEL-212 is a monoclonal antibody targeting CD19.
Phase 2 pipeline
Phase 1 pipeline
- Nitisinone, capsule
- Nitisinone in Arm A
- Nitisinone in Arm B
- SOBI003
- Vitamin B12-ratiopharm N, injection solution
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: